Kleiner Device Labs earned a U.S. patent for its KG2 Surge flow-thru interbody system, the company said Oct. 9.
The KG2 Surge system has been used in 50 cases and is designed to maximize bone graft delivery and streamline implant placement, positioning and integration into the graft matrix.
Kleiner Device Labs has more than 35 global patents for its spine surgery technology.
Stryker CEO Kevin Lobo’s total compensation grew from $20.8 million in 2023 to just under $22 million in 2024, according…
Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive procedure. …
Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has entered…
Comments are closed.